Skip to main content
Top

2025 | OriginalPaper | Hoofdstuk

46. Fluor vaginalis

Auteur : Naoual Tihouna

Gepubliceerd in: Kleine Kwalen en alledaagse klachten bij zwangeren

Uitgeverij: BSL Media & Learning

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

  • Tijdens de zwangerschap neemt de hoeveelheid fysiologische fluor toe.
  • De meest voorkomende oorzaken van fluor vaginalis zijn fysiologische fluor, Candida-infecties en bacteriële vaginose.
  • Candida-infecties en bacteriële vaginose worden alleen behandeld als er sprake is van hinderlijke klachten.
  • Denk ook aan seksueel overdraagbare aandoeningen als mogelijke oorzaak van fluor vaginalis.
Literatuur
2.
go back to reference Disha T, Haque F. Prevalence and risk factors of vulvovaginal candidosis during pregnancy: A review. Infect Dis Obstet Gynecol. 2022 Jul;20(2022):6195712. Disha T, Haque F. Prevalence and risk factors of vulvovaginal candidosis during pregnancy: A review. Infect Dis Obstet Gynecol. 2022 Jul;20(2022):6195712.
3.
go back to reference Kenfack-Zanguim J, Kenmoe S, Bowo-Ngandji A, Kenfack-Momo R, Thierry Ebogo-Belobo J, Kengne-Ndé C, Serge Mbaga D, Zeuko'o Menkem E, Lontuo Fogang R, Tchatchouang S, Laure Ndzie Ondigui J, Irma Kame-Ngasse G, Nina Magoudjou-Pekam J, Roussel Takuissu G, Nkie Esemu S, Nantcho Clavela N, Barriere Fodjo A, Ndip L, Bigoga J, Megnekou R, Esemu LF. Systematic review and meta-analysis of maternal and fetal outcomes among pregnant women with bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol. 2023 Oct;289:9–18. Kenfack-Zanguim J, Kenmoe S, Bowo-Ngandji A, Kenfack-Momo R, Thierry Ebogo-Belobo J, Kengne-Ndé C, Serge Mbaga D, Zeuko'o Menkem E, Lontuo Fogang R, Tchatchouang S, Laure Ndzie Ondigui J, Irma Kame-Ngasse G, Nina Magoudjou-Pekam J, Roussel Takuissu G, Nkie Esemu S, Nantcho Clavela N, Barriere Fodjo A, Ndip L, Bigoga J, Megnekou R, Esemu LF. Systematic review and meta-analysis of maternal and fetal outcomes among pregnant women with bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol. 2023 Oct;289:9–18.
4.
go back to reference Robert L, Goldenberg MD, John C, Hauth MD. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500–7.CrossRef Robert L, Goldenberg MD, John C, Hauth MD. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500–7.CrossRef
5.
go back to reference Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, Pearson J, Lamont RF, Taylor-Robinson D. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol. 1994;101(12):1048.CrossRefPubMed Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, Pearson J, Lamont RF, Taylor-Robinson D. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol. 1994;101(12):1048.CrossRefPubMed
7.
go back to reference Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001;(4):CD000225. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001;(4):CD000225.
8.
go back to reference Zhang Z, Zhang X, Zhou YY, Jiang CM, Jiang HY. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. BJOG. 2019 Dec;126(13):1546–52.CrossRefPubMed Zhang Z, Zhang X, Zhou YY, Jiang CM, Jiang HY. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. BJOG. 2019 Dec;126(13):1546–52.CrossRefPubMed
9.
go back to reference Mølgaard-Nielsen D, Svanström H, Melbye M, Hviid A, Pasternak B. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 2016;315(1):58–67.CrossRefPubMed Mølgaard-Nielsen D, Svanström H, Melbye M, Hviid A, Pasternak B. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 2016;315(1):58–67.CrossRefPubMed
10.
go back to reference Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013;(1):CD000262. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013;(1):CD000262.
11.
go back to reference Klebanoff MA, Schuit E, Lamont RF, Larsson PG, Odendaal HJ, Ugwumadu A, Kiss H, Petricevic L, Andrews WW, Hoffman MK, Shennan A, Seed PT, Goldenberg RL, Emel LM, Bhandaru V, Weiner S, Larsen MD. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: Systematic review and individual participant data meta-analysis. Paediatr Perinat Epidemiol. 2023 Mar;37(3):239–51.CrossRefPubMedPubMedCentral Klebanoff MA, Schuit E, Lamont RF, Larsson PG, Odendaal HJ, Ugwumadu A, Kiss H, Petricevic L, Andrews WW, Hoffman MK, Shennan A, Seed PT, Goldenberg RL, Emel LM, Bhandaru V, Weiner S, Larsen MD. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: Systematic review and individual participant data meta-analysis. Paediatr Perinat Epidemiol. 2023 Mar;37(3):239–51.CrossRefPubMedPubMedCentral
13.
go back to reference Hoffmann E, Váncsa S, Váradi A, Hegyi P, Nagy R, Hamar B, Futács V, Kepkep B, Nyirády P, Demendi C, Ács N. Routine screening of abnormal vaginal flora during pregnancy reduces the odds of preterm birth: a systematic review and meta-analysis. Sci Rep. 2023 Aug 25;13(1):13897.CrossRefPubMedPubMedCentral Hoffmann E, Váncsa S, Váradi A, Hegyi P, Nagy R, Hamar B, Futács V, Kepkep B, Nyirády P, Demendi C, Ács N. Routine screening of abnormal vaginal flora during pregnancy reduces the odds of preterm birth: a systematic review and meta-analysis. Sci Rep. 2023 Aug 25;13(1):13897.CrossRefPubMedPubMedCentral
Metagegevens
Titel
Fluor vaginalis
Auteur
Naoual Tihouna
Copyright
2025
Uitgeverij
BSL Media & Learning
DOI
https://doi.org/10.1007/978-90-368-3107-9_46